Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2016-11-29 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: QUERRIEU (80115), Somme
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE NAFTEUX : revenue, balance sheet and financial ratios
PHARMACIE NAFTEUX is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in QUERRIEU (80115),
this company of category PME
shows in 2022 a revenue of 1.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE NAFTEUX (SIREN 823997739)
Indicator
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
N/C
1 467 925 €
N/C
N/C
N/C
N/C
Net income
145 810 €
131 374 €
568 359 €
148 205 €
155 177 €
159 821 €
78 407 €
EBITDA
N/C
N/C
-51 714 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
38.7%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE NAFTEUX generates positive net income of 146 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 78 k€ -> 146 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
145 810 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 96%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
95.568%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.32%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
Debt ratio
889.947
9.2
239.146
114.72
139.599
117.168
95.568
Financial autonomy
7.947
17.753
26.038
40.796
37.726
42.361
48.32
Repayment capacity
None
None
None
None
-7.641
None
None
Cash flow / Revenue
None%
None%
None%
None%
-15.856%
None%
None%
Sector positioning
Debt ratio
95.572024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-5 pts over 3 years
In 2024, the debt ratio of PHARMACIE NAFTEUX (95.57) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.32%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+11 pts over 3 years
In 2024, the financial autonomy of PHARMACIE NAFTEUX (48.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
-7.64 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE NAFTEUX (-7.64) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 652.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
652.854
Liquidity indicators evolution PHARMACIE NAFTEUX
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
Liquidity ratio
107.021
0.0
0.0
219.632
410.662
450.798
652.854
Interest coverage
None
None
None
None
-12.343
None
None
Sector positioning
Liquidity ratio
652.852024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE NAFTEUX (652.85) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
-12.34x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Watch
In 2022, the interest coverage of PHARMACIE NAFTEUX (-12.3x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE NAFTEUX
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
194 764 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
48
0
0
Customer payment term (days)
0
0
0
0
14
0
0
Supplier payment term (days)
0
0
0
0
56
0
0
Positioning of PHARMACIE NAFTEUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE NAFTEUX is estimated at
2 035 615 €
(range 1 417 570€ - 3 045 397€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1417k€2035k€3045k€
2 035 615 €Range: 1 417 570€ - 3 045 397€
NAF 5 année 2024
Valuation method used
Net Income Multiple
145 810 €
×
14.0x
=2 035 615 €
Range: 1 417 570€ - 3 045 397€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE NAFTEUX with other companies in the same sector:
Frequently asked questions about PHARMACIE NAFTEUX
What is the revenue of PHARMACIE NAFTEUX ?
The revenue of PHARMACIE NAFTEUX in 2022 is 1.5 M€.
Is PHARMACIE NAFTEUX profitable?
Yes, PHARMACIE NAFTEUX generated a net profit of 146 k€ in 2024.
Where is the headquarters of PHARMACIE NAFTEUX ?
The headquarters of PHARMACIE NAFTEUX is located in QUERRIEU (80115), in the department Somme.
Where to find the tax return of PHARMACIE NAFTEUX ?
The tax return of PHARMACIE NAFTEUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE NAFTEUX operate?
PHARMACIE NAFTEUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart